Ocular Therapeutix (OCUL) Non Operating Income (2013 - 2026)

Ocular Therapeutix's Non Operating Income history runs 14 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 3576.47% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $8.9 million (down 21.36% YoY), while the FY2025 annual figure was $4.1 million, up 118.77% from the prior year.
• Non Operating Income was $4.7 million for Q1 2026 at Ocular Therapeutix, down from $5.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $18.7 million in Q3 2023 to a low of -$33.2 million in Q1 2024.
• Historically, Non Operating Income has averaged $241823.5 across 5 years, with a median of -$1000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 114900.0% in 2022, then plunged 3323000.0% in 2024.
• A 5-year view of Non Operating Income shows it stood at $3.8 million in 2022, then plunged by 340.12% to -$9.2 million in 2023, then soared by 123.86% to $2.2 million in 2024, then jumped by 133.36% to $5.1 million in 2025, then slipped by 7.4% to $4.7 million in 2026.
• The last three Non Operating Income figures came in at $4.7 million (Q1 2026), $5.1 million (Q4 2025), and -$720000.0 (Q3 2025), per Business Quant data.